Zydus Lifesciences Extends Timeline for 50:50 Joint Venture with Sunshine Healthcare
Zydus Lifesciences Ltd 路 Others (Uncategorized) 路 02 Oct 2026, 3:05 am
Zydus Lifesciences Extends Timeline for 50:50 Joint Venture with Sunshine Healthcare Zydus Lifesciences Limited and Sunshine Healthcare Lanka Limited have mutually agreed to extend the closing timeline for their proposed 50:50 joint venture, Zydus Sunshine Lifesciences (Private) Limited. Following their initial agreement executed on 26th Jun'26 to acquire a 50% equity stake, both entities executed an extension letter on 1st Oct'26 as condition precedents remain ongoing. The transaction is now expected to reach final completion by Dec'26.
Original exchange filing (PDF)
More announcements from Zydus Lifesciences Ltd
- Press Release 路 14 Nov 2026
- Completion of transaction 路 12 Nov 2026
- Transcript of the post results earnings call held on November 4, 2026. 路 07 Nov 2026
- Press Release 路 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India 路 06 Nov 2026
- Investor Conference 路 06 Nov 2026
- Audio recording of the Company's Investor Call 路 05 Nov 2026
- Press Release 路 04 Nov 2026
